510(k) Report

510(k) · Cleared

Cleared

Synapse 3D Brain Perfusion

K120637510(k) TraditionalCleared May 8, 201268-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fujifilm Medical System U.S.A., Inc. · LLZ System, Image Processing, Radiological

Cleared on May 8, 2012 as substantially equivalent to K103687 (Fujifilm Medical System U.S.A., Inc., 2011) and 1 other predicate after a 68-day review. Its family tree reaches back 11 generations to 1991. 1 later device descends from it.

Decided
May 8, 2012
Review
68 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
2

Its longest line of descent runs back 11 generations to K911667 (1991). 40 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2011: 1 other ancestor1999: 1 other ancestor2004: 1 other ancestor1996: 1 other ancestor2001: 3 other ancestors2000: 3 other ancestors1995: 3 other ancestors1991: 4 other ancestors1994: 4 other ancestors1993: 4 other ancestors1992: 2 other ancestors1998: 1 other ancestor1997: 1 other ancestor2017: 1 descendant clearedReference device: K103465 · Synapse 3D Cardiac Tools · Fujifilm Medical Systems U.S.A, Inc. · 2011K911667 · Hitachi MRP-7000 Magnetic Rosonance Device · Hitachi Medical Systems America, Inc. · 1991 · recalledK963262 · Artoscan M · Biosound, Inc. · 1997K981358 · Artoscan S · Biosound Esaote, Inc. · 1998K990968 · E-SCAN · Biosound Esaote, Inc. · 1999K020164 · E-Scan XQ · Biosound Esaote, Inc. · 2002K032121 · Modification to E-Scan XQ · Esaote, S.p.A. · 2003K042236 · G-SCAN · Esaote, S.p.A. · 2004×2: 2 generations cleared close together, K060956 (2006), K061429 (2006) ×2: 2 generations cleared close together, K073167 (2008), K080762 (2008) 1990200020102020
  1. Root · 11 generations backK911667 Hitachi MRP-7000 Magnetic Rosonance DeviceHitachi Medical Systems America, Inc. · 1991 · Recalled
  2. 7 generations between
  3. 3 generations backK061429 Dynamic Mri Software Option for C-Scan, E-Scan XQ and E-Scan OperaEsaote, S.p.A. · 2006
  4. 2 generations backK073167 Brainstat Software Option for GE Signa MR ScannerGe Medical Systems, LLC · 2008
  5. 1 generation backK080762 IB Neuro, Version 1.0Imaging Biometrics, LLC · 2008
  6. This deviceK120637 Synapse 3D Brain PerfusionFujifilm Medical System U.S.A., Inc. · 2012
  7. Descendant · cites it directly · 0 of its ownK162287 Synapse 3D Perfusion AnalysisFujifilm Medical Systems U.S.A, Inc. · 2017
Show all 11 generations
  1. Root · 11 generations backK911667 Hitachi MRP-7000 Magnetic Rosonance DeviceHitachi Medical Systems America, Inc. · 1991 · Recalled
  2. 10 generations backK963262 Artoscan MBiosound, Inc. · 1997
  3. 9 generations backK981358 Artoscan SBiosound Esaote, Inc. · 1998
  4. 8 generations backK990968 E-SCANBiosound Esaote, Inc. · 1999
  5. 7 generations backK020164 E-Scan XQBiosound Esaote, Inc. · 2002
  6. 6 generations backK032121 Modification to E-Scan XQEsaote, S.p.A. · 2003
  7. 5 generations backK042236 G-SCANEsaote, S.p.A. · 2004
  8. 4 generations backK060956 G-Scan-Model 9800020000, E-Scan Model 9800010000 and E-Scan…Esaote, S.p.A. · 2006
  9. 3 generations backK061429 Dynamic Mri Software Option for C-Scan, E-Scan XQ and E-Scan OperaEsaote, S.p.A. · 2006
  10. 2 generations backK073167 Brainstat Software Option for GE Signa MR ScannerGe Medical Systems, LLC · 2008
  11. 1 generation backK080762 IB Neuro, Version 1.0Imaging Biometrics, LLC · 2008
  12. This deviceK120637 Synapse 3D Brain PerfusionFujifilm Medical System U.S.A., Inc. · 2012

Most influential descendants

Showing 1 of 1 · See all
  • K162287Synapse 3D Perfusion AnalysisFujifilm Medical Systems U.S.A, Inc. · 2017 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−11K911667Hitachi MRP-7000 Magnetic Rosonance DeviceHitachi Medical Systems America, Inc.19912
−10K963262Artoscan MBiosound, Inc.1997—
−9K981358Artoscan SBiosound Esaote, Inc.1998—
−8K990968E-SCANBiosound Esaote, Inc.1999—
−7K020164E-Scan XQBiosound Esaote, Inc.2002—
−6K032121Modification to E-Scan XQEsaote, S.p.A.2003—
−5K042236G-SCANEsaote, S.p.A.2004—
−4K060956G-Scan-Model 9800020000, E-Scan Model 9800010000 and E-Scan…Esaote, S.p.A.2006—
−3K061429Dynamic Mri Software Option for C-Scan, E-Scan XQ and E-Scan OperaEsaote, S.p.A.2006—
−2K073167Brainstat Software Option for GE Signa MR ScannerGe Medical Systems, LLC2008—
−1K080762IB Neuro, Version 1.0Imaging Biometrics, LLC2008—
0 (this device)K120637Synapse 3D Brain PerfusionFujifilm Medical System U.S.A., Inc.2012—
+1K162287Synapse 3D Perfusion AnalysisFujifilm Medical Systems U.S.A, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199140
199220
199340
199440
199530
199610
199710
199810
199910
200030
200130
200410
201110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
FIG. 1 — Lineage of K120637, 1991–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K103687Synapse 3D Cerebral Analysis
Summary page 2
…FILM Medical Systems U.S.A., Inc. Synapse 3D Brain Perfusion (V3.0) 510(k) Predicate Device: *Synapse 3D Cerebral Analysis, FUJIFILM Medical Systems U.S.A., Inc. (K1 03687) * B Neuro vi .0, Imaging Biometrics, LLC (K080762) Description of the Device. Synapse 3D Brain Perfusion (V3.0) is the u…
Fujifilm Medical System U.S.A., Inc.2011—
*K080762IB Neuro, Version 1.0
Summary page 2
…on (V3.0) 510(k) Predicate Device: *Synapse 3D Cerebral Analysis, FUJIFILM Medical Systems U.S.A., Inc. (K1 03687) * B Neuro vi .0, Imaging Biometrics, LLC (K080762) Description of the Device. Synapse 3D Brain Perfusion (V3.0) is the updated version of previously-cleared Synapse 3D Cerebral…
Imaging Biometrics, LLC2008—
†K103465Synapse 3D Cardiac ToolsFujifilm Medical Systems U.S.A, Inc.2011—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K162287Synapse 3D Perfusion AnalysisFujifilm Medical Systems U.S.A, Inc.20170

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 7 companies; a new generation was cleared every 1.4 years on median.
  • 7 of the 40 ancestors have a recall of any class.
  • Of its descendants, K162287 (Fujifilm Medical Systems U.S.A, Inc., 2017) has gone furthest, with 0 descendants of its own.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

Synapse 3D Brain Perfusion is medical imaging software used with Synapse 3D Base Tools that is intended to provide trained medical professionals with tools to aid them in reading, interpreting, reporting, and treatment planning. Synapse 3D Brain Perfusion accepts DICOM conmpliant medical images acquired from CT and MR. This product is not intended for use with or for the primary diagnostic interpretation of Mammography images. Addition to Synapse 3D Base…

Read the full statement (125 words)

Synapse 3D Brain Perfusion is medical imaging software used with Synapse 3D Base Tools that is intended to provide trained medical professionals with tools to aid them in reading, interpreting, reporting, and treatment planning. Synapse 3D Brain Perfusion accepts DICOM conmpliant medical images acquired from CT and MR.

This product is not intended for use with or for the primary diagnostic interpretation of Mammography images.

Addition to Synapse 3D Base Tools, Synapse 3D Brain Perfusion provides the parameter images by post-processing with dynamic scanned CT cerebral arteriography images and magnetic resonance images (MR) with contrast agent to aid the assessment of cerebral blood flow. The parameter images are Cerebral Blood Volume (CBV), Cerebral Bbood Flow (CBF), Mean Transit Time (MUT), and Time To Peak (UTP).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K120637: Synapse 3D Brain Perfusion.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K120637

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026